Full-field digital mammography (FFDM) has been the “go to” imaging modality to screen for early detection of breast cancer for […]
Posts Tagged ‘Clinical Trial’
ABUS and DBT and FFDM
It was five years ago that we published a key article in Diagnostics, an open-access journal, in which we described our dual-modality […]
Learning from Past Mistakes
Almost 25 years ago, in 1998, the FDA approved computer-aided detection (CAD) tools as an adjunct to mammography. This was before the […]
Efficacy of Breast Self-Exams
It is widely accepted that when breast cancer is diagnosed early and remains localised, effective treatment yields a five-year survival […]
Cape Town Company Develops Covid-19 Test Kit
Five years ago, CapeRay joined a consortium of local manufacturers to establish a not-for-profit company called the Western Cape Medical Devices […]
Evaluating DBT after 10 Years
Earlier this year, we described how the digital breast tomosynthesis (DBT) pioneers, led by Dr Daniel Kopans, developed a screening tool that […]
What if it’s not Randomized?
The National Cancer Institute in the USA defines a randomized clinical trial as: “A study in which the participants are divided by […]
Benefits of Screening Recognised
The Radiological Society of North America (RSNA) has just announced that the Alexander Margulis Award for Scientific Excellence in 2021 has been […]
Is AI Ready for Breast Screening?
Judging by their marketing, companies are gearing up for widespread adoption of their artificial intelligence (AI) algorithms by breast screening […]
Optimising Breast Cancer Screening
Six years ago, we reviewed a paper published in The Lancet by the Japan Strategic Anti-Cancer Randomized Trial (J-START) in which the […]